140 search results for: burden of disease

Prevalence <b>of</b> Food Allergy and Other Atopic Comorbidities in Children With AD
Dermatology
Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD
expert video

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Mark Boguniewicz discusses the prevalence of food sensitization and food allergy in pediatric patients with AD, clarifying the difference between the two. Dr Boguniewicz also discusses the prevalence of other atopic comorbidities in children with AD

View more
The Impacts <b>of</b> Delayed Diagnosis and Treatment in Bullous Pemphigoid
Dermatology
The Impacts of Delayed Diagnosis and Treatment in Bullous Pemphigoid
expert video

Professor Dédée Murrell highlights the importance of early diagnosis in bullous pemphigoid at EADV 2025

View more
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Dermatology
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Podcast

Professor Lisa Beck explores the chronic and persistent burden of atopic dermatitis (AD) as well as the concept of early intervention in patients with AD.

View more
Persistence <b>of</b> AD From Childhood Into Adulthood
Dermatology
Persistence of AD From Childhood Into Adulthood
expert video

In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert describes how AD can persist into adulthood in many children with moderate-to-severe AD and discusses the risk factors for such persistence.

View more
Monitoring Lung Function Is an Important Aspect <b>of</b> Pediatric Asthma Management
Pulmonology
Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
interactivity

Navigate through this interactive infographic to learn more about why lung function is important to monitor in pediatric patients with asthma and the noninvasive procedures that are available for implementation in clinical practice.

View more
Novel Treatments for Bullous Pemphigoid
Dermatology
Novel Treatments for Bullous Pemphigoid
expert video

Join Dr. Murell as she shares novel treatments for bullous pemphigoid and how these may help fill current gaps in treatment options.

View more
Type 2 Inflammation Contributes to Itch and Fibrois in PN
Dermatology
Type 2 Inflammation Contributes to Itch and Fibrois in PN
expert video

Join Dr. Kwatra outlining the micro itch cycle involving type 2 cell polarization and cytokines that directly affect fibroblasts to cause more immune dysregulation in PN.

View more
Why Is It Important to Assess Lung Function in Pediatric Asthma?
Pulmonology
Why Is It Important to Assess Lung Function in Pediatric Asthma?
interactivity

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.

View more
Factors Contributing to Diagnostic Delays in Bullous Pemphigoid
Dermatology
Factors Contributing to Diagnostic Delays in Bullous Pemphigoid
expert video

Dr. Donna Culton focuses on the challenges of diagnosis and the unmet needs for patients with BP

View more
Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
Dermatology
Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
expert video

Professors Metz, Netchiporouk, and Hawkes discuss the clinical features, pathophysiology, and therapeutic landscape of CSU, at EADV 2025.

View more
ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?
Pulmonology
ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?
expert video

Professors Celeste Porsbjerg and Klaus Rabe and Dr Mario Castro discuss the pathophysiology of airway remodeling and its impact on patients with severe asthma.

View more
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.